Long-lasting effect of a single botulinum toxin injection in the treatment of oropharyngeal dysphagia secondary to upper esophageal sphincter dysfunction: A pilot study

Scandinavian Journal of Gastroenterology

Volumn 43, Issue 11, 2008, Pages 1296-1303

  Terré, Rosa ^a   Vallès, Margarida ^a   Panadés, Agustí ^a   Mearin, Fermín ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b University Institute affiliated with the Autonomous University of Barcelona   (Spain)

Author keywords

Botulinum toxin; Brain injury; Cricopharyngeus muscle; Dysphagia; Spinal cord injury

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; AMPLITUDE MODULATION; ARTICLE; ASPIRATION; BRAIN DAMAGE; CERVICAL SPINAL CORD INJURY; CLINICAL ARTICLE; CRICOPHARYNGEUS MUSCLE; DRUG EFFICACY; DYSPHAGIA; ENDOSCOPY; ESOPHAGUS FUNCTION DISORDER; FEMALE; FLUOROSCOPY; FOLLOW UP; HUMAN; LOWER ESOPHAGUS SPHINCTER; MALE; MANOMETRY; NOSE FEEDING; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SWALLOWING;

ADULT; AGED; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; DEGLUTITION DISORDERS; ESOPHAGEAL SPHINCTER, UPPER; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; PILOT PROJECTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 54349106218     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520802245403     Document Type: Article

References (35)

1. Saeian K, Shaker R. Management of swallowing disorders. In: Eamonn MM Quigley, Ronald F. Pfeiffer. Neuro-gastroenterology. 1st ed. Philadelphia; 2004. p. 275-301.
2. Parameswaran MS. Endoscopic botulinum toxin injection for cricopharyngeal dysphagia. Ann Otol Rhinol Laryngol 2002;111:871-4.
3. Wilson J.A, Pryde A, Allan PL, Maran AG. Cricopharyngeal dysfunction. Otolaryngol Head Neck Surg 1992;106:163-8.
4. Kelly JH. Use of manometry in the evaluation of dysphagia. Otolaryngol Head Neck Surg 1997;116:355-7.
5. Logemann JA. Role of the modified barium swallow in management of patients with dysphagia. Otolaryngol Head Neck Surg 1997;116:335-8.
6. Lacau St Guily JPS, Willing TN, Chaussade S, Eymard B, Angelard B. Swallowing disorders in muscular diseases: functional assessment and indication of cricopharyngeal myotomy. Ear Nose Throat J 1994;73:34-40.
7. Ahsan SF, Meleca RJ, Dworkin JP. Botulinum toxin injection of the cricopharyngeus muscle for the treatment of dysphagia. Otolaryngol Head Neck Surg 2000;122:691-5.
8. McKenna JA, Dedo HH. Cricopharyngeal myotomy: indications and technique. Ann Otol Rhinol Laryngol 1992;101:216-21.
9. Ross ER, Green R, Auslander MO, Biller HF. Cricopharyngeal myotomy: management of cervical dysphagia. Otolaryngol Head Neck Surg 1982;90: 434-41.
10. Woodson G. Cricopharyngeal myotomy and arytenoid adduction in the management of combined laryngeal and pharyngeal paralysis. Otolaryngol Head Neck Surg 1997;116:339-43.
11. Singer MI, Blom ED, Hamaker RC. Pharyngeal plexus neurectomy for alaryngeal speech rehabilitation. Laryngoscope 1986;96:50-4.
12. Schneider I, Pototschnig C, Thumfart WK, Eckel HE. Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method. Ann Otol Rhinol Laryngol 1994;103:31-5.
13. Blitzer A, Brin MF. Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia. Otolaryngol Head Neck Surg 1997;116:328-30.
14. Van den Bergh P, Francart J, Mourin S, Kollmann P, Laterre EC. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin. Muscle Nerve 1995;18:720-9.
15. Gelb DJ, Lowenstein DH, Aminoff MJ. Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis. Neurology 1989;39:80-4.
16. Borodic GE, Joseph M, Fay L, Cozzolino D, Ferrante RJ. Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread. Head Neck 1990;12:392-9.
17. Blitzer A, Brin A, Fahn S, Lovelace RE. Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia). Laryngoscope 1988;98:193-7.
18. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995;332:774-8.
19. Cuilliere C, Ducrotté P, Zerbib F, Metman EH, de Looze D, Guillemot F, et al. Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut 1997;41:87-92.
20. Zarate N MF, Baldovino F, Armengol JR, Malagelada JR. Achalasia treatment in the elderly: is botulinum toxin injection the best option? Eur J Gastroenterol Hepatol 2002;14:285-90.
21. Murry T, Wasserman T, Carrau RL, Castillo B. Injection of botulinum toxin A for the treatment of dysfunction of the upper esophageal sphincter. Am J Otolaryngol 2005;26:157-62.
22. Alberty J, et al. Efficacy of botulinum toxin A for treatment of upper esophageal sphincter dysfunction. Laryngoscope 2000;110:1151-6.
23. Logemann JA. Measurement of swallow from videofluorographic studies. In: Logemann JA. Manual for the videofluorographic study of swallowing. Austin Texas Editor; 1993. pp 115-26.
24. Grupo español para el estudio de la motilidad digestiva (GEEMD). Manometría esofágica convencional. In: Benages A, coordinador. Técnicas para el estudio de la actividad motora digestiva: protocolos metodológicos. Ed. Barcelona: Laboratorio Menarini; 1997. pp 11-25.
25. Baredes S, Shah CS, Kaufman R. The frequency of cricopharyngeal dysfunction on videofluoroscopic swallowing studies in patients with dysphagia. Am J Otolaryngol 1997;18:85-9.
26. Born LJ, Harned RH, Rikkers LF, Pfeiffer RF, Quigley EM. Cricopharyngeal dysfunction in Parkinson's disease: role in dysphagia and response to myotomy. Mov Disord 1996;11:53-8.
27. Brant CQ, Siqueira ES, Ferrari AP Jr. Botulinum toxin for oropharyngeal dysphagia: case report of flexible endoscope-guided injection. Dis Esophagus 1999;121:68-73.
28. Zaninotto G, Marchese Ragona R, Briani C, Costantini M, Rizzetto C, Portale G, et al. The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia. J Gastrointest Surg 2004;8:997-1006.
29. Haapaniemi JJ, Laurikainen EA, Pulkinnin J, Martilla RJ. Botulinum toxin in the treatment of cricopharyngeal dysphagia. Dysphagia 2001;16:171-5.
30. Shaw GY, Searl JP. Botulinum toxin treatment for cricopharyngeal dysfunction. Dysphagia 2001;16:61-7.
31. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial. Ann Intern Med 1994;121:590-1.
32. Marchese-Ragona R, De Grandis D, Restivo Da, Staffieri A, Marioni G, Pastore A. Recovery of swallowing disorders in patients undergoing supracricoid laryngectomy with botulinum toxin therapy. Ann Otol Rhinol Laryngol 2003;112:258-63.
33. Chiu MJ, Chang YC, Hsiao TY. Prolonged effect of botulinum toxin injection in the treatment of cricopharyngeal dysphagia: case report and literature review. Dysphagia 2004;19:52-7.
34. Kim DY, Park CI, Ohn SH, Moon JY, Chang WH, Park SW. Botulinum toxin type A for poststroke cricopharyngeal muscle dysfunction. Arch Phys Med Rehabil 2006;87:1346-51.
35. Ravich WJ. Botulinum toxin for UES dysfunction: therapy or poison? Dysphagia 2001;16:168-70.